Joaquin Duato, J&J CEO (Amir Hamja/Bloomberg via Getty Images)
September 2, 2022 01:47 PM EDT
Law

J&J coughs up $40.5M in New Hamp­shire opi­oid set­tle­ment, evad­ing up­com­ing tri­al

Aayushi Pratap

News Reporter

J&J has agreed to shell out $40.5 mil­lion to set­tle New Hamp­shire state’s al­leged claims over the com­pa­ny’s role in fu­el­ing the US opi­oid cri­sis …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times